Muscarinic receptors mediate carbachol-induced inhibition of maximal electroshock seizures in the nucleus reticularis pontis oralis

Epilepsia

Volumn 40, Issue 1, 1999, Pages 20-25

  Peterson, Steven L ^a,b   Armstrong, Juli J ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Cholinergic; Maximal electroshock; Nucleus reticularis pontis oralis; Pertussis toxin

Indexed keywords

CARBACHOL; MUSCARINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRIC SHOCK; ELECTRODE; MALE; MICROINJECTION; NONHUMAN; PONS RETICULAR FORMATION; PRIORITY JOURNAL; RAT; SEIZURE;

ANIMALS; ATROPINE; CARBACHOL; CHOLINERGIC AGONISTS; DIMETHYLPHENYLPIPERAZINIUM IODIDE; ELECTROSHOCK; HINDLIMB; MALE; MESENCEPHALON; MICROINJECTIONS; PONS; RATS; RATS, WISTAR; RECEPTORS, MUSCARINIC; RETICULAR FORMATION; SEIZURES; STEREOTAXIC TECHNIQUES; TEGMENTUM MESENCEPHALI;

EID: 0032952888     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb01983.x     Document Type: Article

References (29)

1. Browning R, Turner F, Simonton R, Bundman M. Effect of midbrain and pontine tegmental lesions on the maximal electroshock pattern in rats. Epilepsia 1981;22:583-94.
2. Browning R, Simonton R, Turner F. Antagonism of experimentally induced seizures following a lesion in the midbrain tegmentum. Epilepsia 1981;22:595-601.
3. Browning RA, Nelson DK, Mogharreban N, Jobe PC, Laird HE. Effect of midbrain and pontine tegmental lesions on audiogenic seizures in genetically epilepsy-prone rats. Epilepsia 1985;26:175-83.
4. Swinyard EA, Woodhead HS, White HS, Franklin MR. Experimental selection, quantification, and evaluation of anticonvulsants. In: Levy RH, Dreyfuss FE, Mattson RM, Meldrum BS, Penry JK, eds. Antiepileptic drugs. New York: Raven Press, 1989:85.
5. Peterson SL. Electroshock. In: Peterson SL, Albertson TE, eds. Neuropharmacology methods in epilepsy research. Boca Raton, FL: CRC Press 1998:1-26.
6. Peterson SL. Localization of an anatomic substrate for the anticonvulsant activity induced by D-cycloserine. Epilepsia 1994; 35:933-8.
7. Peterson, SL. Infusion of NMDA antagonists into the nucleus reticularis pontis oralis inhibits the maximal electroshock seizure response. Brain Res 1995;702:101-9.
8. Browning RA. The role of neurotransmitters in electroshock seizure models. In: Jobe PC, Laird HE III, eds. Neurotransmitters and epilepsy. Clifton, NJ: Humana Press, 1987:277-320.
9. Zablocka B, Esplin DW. Central excitatory and depressant effects of pilocarpine in rats and mice. J Pharmacol Exp Ther 1963;140: 162-9.
10. Kleinrok Z, Wielosz M, Poddubiuk Z. Central action of drugs acting on the cholinergic muscarinic receptor. Arch Immunol Ther Exp 1975;23:465-75.
11. Zebrowska-Lupina I, Kleinrok Z, Poddubiuk Z. Central action of drugs acting on the cholinergic muscarinic receptor. Arch Immunol Ther Exp 1975;23:485-95.
12. Bhattacharya SK, Sen AP, Mitra SK. Effects of muscarinic receptor agonists and antagonists on response of non-extensor rats to maximal electroshock. Indian J Exp Biol 1991;29:237-40.
13. Peterson SL. Anticonvulsant drug potentiation by glycine in maximal electroshock seizures is mimicked by D-serine and antagonized by 7-chlorokynurenic acid. Eur J Pharmacol 1991;199:341-8.
14. Pellegrino LJ, Pellegrino AS, Cushman AJ. A stereotaxic atlas of the rat brain. New York: Plenum Press, 1979.
15. Van Rossum JM. Classification and molecular pharmacology of ganglionic blocking agents. Int J Pharmacol 1962;1:97-110.
16. Peterson SL. The effect on maximal electroshock seizures induced by GABA agents and antiepileptic drugs microinfused into the nucleus reticularis pontis oralis. Epilepsy Res 1996;25:161-7.
17. Freissmuth M, Casey PJ, Gilman AG. G proteins control diverse pathways of transmembrane signaling. FASEB J 1989;3:2125-31.
18. Wess J. Mutational analysis of muscarinic acetylcholine receptors: structural basis of ligand/receptor/G protein interactions. Life Sci 1993;53:1447-63.
19. Shuman SL, Capece ML, Baghdoyan HA, Lydic R. Pertussis toxin-sensitive G proteins mediate carbachol-induced REM sleep and respiratory depression. Am J Physiol 1995;38:R308-17.
20. McKinney M, Miller JH, Aagaard PJ. Pharmacological characterization of the rat hippocampal muscarinic autoreceptor. J Pharmacol Exp Ther 1993;264:74-8.
21. Marchi M, Raiteri M. Interaction of acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors. J Pharmacol Exp Ther 1989;248:1255-60.
22. Elazar Z, Feldman Z. Brainslem experimental seizures produced by microinjections of carbachol. Epilepsia 1987;28:463-70.
23. Myers RD. Experimental methods for stimulating the brain with chemicals. In: Handbook of drug and chemical stimulation of the brain. New York: Van Nostrand Reinhold, 1974:42-77.
24. Myers RD. Injection of solutions into cerebral tissue: relation between volume and diffusion. Physiol Behav 1966;1:171-4.
25. Bondareff W, Routtenberg A, Narotzky R, McLone DG. Intrastriatal spreading of biogenic amines. Exp Neurol 1970;28:213-29.
26. Rech RH, Domino EF. Observations on injections of drugs into the brain substance. Arch Int Pharmacodyn 1959;CXXI:429-42.
27. Carvey PM, Maag TJ, Lin D. Injection of biologically active substances into the brain. In: Flanagan TR, ed. Providing pharmacological access to the brain: alternate approaches. San Diego, CA: Academic Press, 1994:214-34.
28. Tortorella A, Halonen T, Sahibzada N, Gale K. A crucial role of the α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype of glutamate receptors in piriform and perirhinal cortex for the initiation and propagation of limbic motor seizures. J Pharmacol Exp Ther 1997;280:1401-5.
29. Tizzano JP, Griffey KI, Johnson JA, Fix AS, Helton DR, Schoepp DD. Intracerebral 1S,3R-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R-ACPD) produces limbic seizures that are not blocked by ionotropic glutamate receptor antagonists. Neurosci Lett 1993; 162:12-6.